Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Qiagen NV (NASDAQ:QGEN)

26.66
Delayed Data
As of Sep 23
 -0.21 / -0.78%
Today’s Change
19.94
Today|||52-Week Range
28.04
-3.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$6.4B

Company Description

QIAGEN NV manufactures and distributes sample and assay technology products for preanalytical sample preparations. Its products include instruments, consumables, and detection technologies. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, Netherlands.

Contact Information

QIAGEN NV
Hulsterweg 82
Venlo Limburg 5912 PL
P:(177) 355-6600
Investor Relations:

Employees

Shareholders

Mutual fund holders46.65%
Other institutional21.39%
Individual stakeholders--

Top Executives

Peer Michael SchatzChief Executive Officer
Douglas LiuSenior Vice President-Global Operations
Roland SackersChief Financial Officer
Tadd S. LazarusChief Medical Officer
Bradford J. CrutchfieldSenior VP-Life Sciences Business Area